![Takehiko Sawabe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takehiko Sawabe
Director/Board Member at Quantum Biosystems, Inc.
Profile
Takehiko Sawabe is currently a Director at Anaeropharma Science, Inc., an Outside Director at Quantum Biosystems, Inc., and an Outside Director at SCOHIA PHARMA, Inc. He was previously a Director at Megakaryon Corp.
Sawabe received an undergraduate degree from the University of Tokyo and an MBA from GLOBIS University.
Takehiko Sawabe active positions
Companies | Position | Start |
---|---|---|
Quantum Biosystems, Inc.
![]() Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Director/Board Member | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
SCOHIA PHARMA, Inc.
![]() SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Director/Board Member | - |
Former positions of Takehiko Sawabe
Companies | Position | End |
---|---|---|
Megakaryon Corp.
![]() Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Director/Board Member | - |
Training of Takehiko Sawabe
University of Tokyo | Undergraduate Degree |
GLOBIS University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Quantum Biosystems, Inc.
![]() Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Health Technology |
Megakaryon Corp.
![]() Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Health Services |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
SCOHIA PHARMA, Inc.
![]() SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Commercial Services |
- Stock Market
- Insiders
- Takehiko Sawabe